lynda

2016 Cedar Pollen Allergy Market Therapeutics H1 Pipeline Assessment

Press Release   •   May 12, 2016 07:57 EDT

In-detail Table of Contents of Cedar Pollen Allergy Pipeline Market

Companies involved in this research ALK-Abello A/S, Anergis SA, Circassia Pharmaceuticals Plc, Immunomic Therapeutics, Inc. and Japan Tobacco Inc.

This report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Get discount on this research at http://www.rnrmarketresearch.com/contacts/discount?rname=542571 .

Scope for this research:

  • The report provides a snapshot of the global therapeutic landscape of Cedar Pollen Allergy
  • The report reviews pipeline therapeutics for Cedar Pollen Allergy by companies and universities/research institutes based on information derived from company and industry-specific sources
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report reviews key players involved Cedar Pollen Allergy therapeutics and enlists all their major and minor projects
  • The report assesses Cedar Pollen Allergy therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report summarizes all the dormant and discontinued pipeline projects
  • The report reviews latest news related to pipeline therapeutics for Cedar Pollen Allergy

Complete research report at http://www.rnrmarketresearch.com/cedar-pollen-allergy-pipeline-review-h1-2016-market-report.html .

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

List of figures:

  • Number of Products under Development for Cedar Pollen Allergy, H1 2016
  • Number of Products under Development for Cedar Pollen Allergy - Comparative Analysis, H1 2016
  • Number of Products under Development by Companies, H1 2016
  • Comparative Analysis by Clinical Stage Development, H1 2016
  • Comparative Analysis by Early Stage Products, H1 2016
  • Assessment by Monotherapy Products, H1 2016
  • Number of Products by Routes of Administration, H1 2016
  • Number of Products by Stage and Top 10 Routes of Administration, H1 2016
  • Number of Products by Molecule Types, H1 2016
  • Number of Products by Stage and Top 10 Molecule Types, H1 2016

About Us:

RnRMarketResearch.com is an online database of market research reports offer in-depth analysis of over 5000 market segments. The library has syndicated reports by leading market research publishers across the globe and also offer customized market research reports for multiple industries.